Search companies or stocks...
SAVACassava Sciences, Inc.
At close · 22 May 2026, 04:35 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small…
Current stock price of Cassava Sciences, Inc. (SAVA) stock is $1.320. The stock price is +2.33% higher in the session. The intraday range can be seen from this page. Volume of Cassava Sciences, Inc. (SAVA) stock is 134.26K.
Last updated at 22 May 2026, 04:35 pm.
The stock price of Cassava Sciences, Inc. (SAVA) can change with earnings, company news, and overall market sentiment. Cassava Sciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Cassava Sciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SAVA on this page is -0.59. EPS on this page is -2.22. Compare those figures with peers and growth expectations before deciding if the current Cassava Sciences, Inc. price is justified.
Historical performance for Cassava Sciences, Inc. (SAVA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SAVA reacted to past earnings and market events.
Buying Cassava Sciences, Inc. (SAVA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
